▶ 調査レポート

バイオ契約開発及び製造組織(CDMO)の世界市場 2020年

• 英文タイトル:Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。バイオ契約開発及び製造組織(CDMO)の世界市場 2020年 / Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / GIR201113691資料のイメージです。• レポートコード:GIR201113691
• 出版社/出版日:GlobalInfoResearch / 2020年10月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、バイオ契約開発及び製造組織(CDMO)の世界市場を調査対象にし、バイオ契約開発及び製造組織(CDMO)の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(API開発、製造、ドラッグデリバリー)、用途別分析(製薬会社、バイオテクノロジー会社、ジェネリック会社)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Lonza、Catalent、Fujifilm、Boehringer ‎Ingelheim、Ardena、Celltrion、Amgen、Ology Bio、Selexis、AGC
・企業別売上、市場シェア
・バイオ契約開発及び製造組織(CDMO)の地域別市場分析
・バイオ契約開発及び製造組織(CDMO)の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・バイオ契約開発及び製造組織(CDMO)のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・バイオ契約開発及び製造組織(CDMO)のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・バイオ契約開発及び製造組織(CDMO)の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・バイオ契約開発及び製造組織(CDMO)の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・バイオ契約開発及び製造組織(CDMO)の種類別市場規模2015-2020:API開発、製造、ドラッグデリバリー
・バイオ契約開発及び製造組織(CDMO)の用途別市場規模2015-2020:製薬会社、バイオテクノロジー会社、ジェネリック会社
・バイオ契約開発及び製造組織(CDMO)の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論

Market Overview
The global Bio Contract Development and Manufacturing Organizations (CDMOs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Bio Contract Development and Manufacturing Organizations (CDMOs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Bio Contract Development and Manufacturing Organizations (CDMOs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Bio Contract Development and Manufacturing Organizations (CDMOs) market has been segmented into:
API Development
Manufacturing
Drug Delivery

By Application, Bio Contract Development and Manufacturing Organizations (CDMOs) has been segmented into:
Pharmaceutical Company
Biotechnology Company
Generic Company

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bio Contract Development and Manufacturing Organizations (CDMOs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Bio Contract Development and Manufacturing Organizations (CDMOs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bio Contract Development and Manufacturing Organizations (CDMOs) market.

The report offers in-depth assessment of the growth and other aspects of the Bio Contract Development and Manufacturing Organizations (CDMOs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share Analysis
Bio Contract Development and Manufacturing Organizations (CDMOs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Bio Contract Development and Manufacturing Organizations (CDMOs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bio Contract Development and Manufacturing Organizations (CDMOs) sales, revenue and market share for each player covered in this report.

The major players covered in Bio Contract Development and Manufacturing Organizations (CDMOs) are:
Lonza
Catalent
Fujifilm
Boehringer ‎Ingelheim
Ardena
Celltrion
Amgen
Ology Bio
Selexis
AGC

レポート目次

Table of Contents

1 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Overview
1.1 Product Overview and Scope of Bio Contract Development and Manufacturing Organizations (CDMOs)
1.2 Classification of Bio Contract Development and Manufacturing Organizations (CDMOs) by Type
1.2.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type in 2019
1.2.3 API Development
1.2.4 Manufacturing
1.2.5 Drug Delivery
1.3 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market by Application
1.3.1 Overview: Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market by Regions
1.4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Bio Contract Development and Manufacturing Organizations (CDMOs) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Bio Contract Development and Manufacturing Organizations (CDMOs) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Bio Contract Development and Manufacturing Organizations (CDMOs) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bio Contract Development and Manufacturing Organizations (CDMOs) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Bio Contract Development and Manufacturing Organizations (CDMOs) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bio Contract Development and Manufacturing Organizations (CDMOs) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Lonza SWOT Analysis
2.1.4 Lonza Product and Services
2.1.5 Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Catalent SWOT Analysis
2.2.4 Catalent Product and Services
2.2.5 Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fujifilm
2.3.1 Fujifilm Details
2.3.2 Fujifilm Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fujifilm SWOT Analysis
2.3.4 Fujifilm Product and Services
2.3.5 Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer ‎Ingelheim
2.4.1 Boehringer ‎Ingelheim Details
2.4.2 Boehringer ‎Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer ‎Ingelheim SWOT Analysis
2.4.4 Boehringer ‎Ingelheim Product and Services
2.4.5 Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ardena
2.5.1 Ardena Details
2.5.2 Ardena Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ardena SWOT Analysis
2.5.4 Ardena Product and Services
2.5.5 Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celltrion SWOT Analysis
2.6.4 Celltrion Product and Services
2.6.5 Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ology Bio
2.8.1 Ology Bio Details
2.8.2 Ology Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Ology Bio SWOT Analysis
2.8.4 Ology Bio Product and Services
2.8.5 Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Selexis
2.9.1 Selexis Details
2.9.2 Selexis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Selexis SWOT Analysis
2.9.4 Selexis Product and Services
2.9.5 Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
2.10 AGC
2.10.1 AGC Details
2.10.2 AGC Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AGC SWOT Analysis
2.10.4 AGC Product and Services
2.10.5 AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Bio Contract Development and Manufacturing Organizations (CDMOs) Players Market Share
3.2.2 Top 10 Bio Contract Development and Manufacturing Organizations (CDMOs) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Market Share by Regions
4.2 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
4.3 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
4.5 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
5 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries
5.1 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
5.2 USA Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
5.3 Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
5.4 Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
6 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries
6.1 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
6.2 Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
6.3 UK Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
6.4 France Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
6.5 Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
6.6 Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries
7.1 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
7.2 China Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
7.3 Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
7.4 Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
7.5 India Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
8 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries
8.1 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
8.2 Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
8.3 Argentina Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Bio Contract Development and Manufacturing Organizations (CDMOs) by Countries
9.1 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
9.3 UAE Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
9.4 Egypt Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
9.5 South Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Market Share by Type (2015-2020)
10.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast by Type (2019-2024)
10.3 API Development Revenue Growth Rate (2015-2025)
10.4 Manufacturing Revenue Growth Rate (2015-2025)
10.5 Drug Delivery Revenue Growth Rate (2015-2025)
11 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Segment by Application
11.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application (2015-2020)
11.2 Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Company Revenue Growth (2015-2020)
11.4 Biotechnology Company Revenue Growth (2015-2020)
11.5 Generic Company Revenue Growth (2015-2020)
12 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Forecast (2021-2025)
12.1 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Size Forecast (2021-2025)
12.2 Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Forecast by Regions (2021-2025)
12.3 North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
12.4 Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
12.6 South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Bio Contract Development and Manufacturing Organizations (CDMOs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Lonza Corporate Information, Location and Competitors
Table 6. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 7. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 8. Lonza SWOT Analysis
Table 9. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 10. Lonza Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Catalent Corporate Information, Location and Competitors
Table 12. Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 13. Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2018-2019)
Table 14. Catalent SWOT Analysis
Table 15. Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 16. Catalent Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Fujifilm Corporate Information, Location and Competitors
Table 18. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 19. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 20. Fujifilm SWOT Analysis
Table 21. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 22. Fujifilm Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Boehringer ‎Ingelheim Corporate Information, Location and Competitors
Table 24. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 25. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 26. Boehringer ‎Ingelheim SWOT Analysis
Table 27. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 28. Boehringer ‎Ingelheim Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ardena Corporate Information, Location and Competitors
Table 30. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 31. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 32. Ardena SWOT Analysis
Table 33. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 34. Ardena Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Celltrion Corporate Information, Location and Competitors
Table 36. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 37. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 38. Celltrion SWOT Analysis
Table 39. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 40. Celltrion Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Amgen Corporate Information, Location and Competitors
Table 42. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 43. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 46. Amgen Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Ology Bio Corporate Information, Location and Competitors
Table 48. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 49. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 50. Ology Bio SWOT Analysis
Table 51. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 52. Ology Bio Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Selexis Corporate Information, Location and Competitors
Table 54. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 55. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 56. Selexis SWOT Analysis
Table 57. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 58. Selexis Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. AGC Corporate Information, Location and Competitors
Table 60. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Major Business
Table 61. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Total Revenue (USD Million) (2017-2018)
Table 62. AGC SWOT Analysis
Table 63. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Product and Solutions
Table 64. AGC Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) by Players (2015-2020)
Table 66. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Players (2015-2020)
Table 67. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Regions (2015-2020)
Table 69. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
Table 70. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Table 71. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Countries (2015-2020)
Table 74. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Table 77. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) by Type (2015-2020)
Table 78. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Type (2015-2020)
Table 79. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Forecast by Type (2021-2025)
Table 80. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue by Application (2015-2020)
Table 81. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Application (2015-2020)
Table 82. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Forecast by Application (2021-2025)
Table 83. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Bio Contract Development and Manufacturing Organizations (CDMOs) Picture
Figure 2. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Type in 2019
Figure 3. API Development Picture
Figure 4. Manufacturing Picture
Figure 5. Drug Delivery Picture
Figure 6. Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Application in 2019
Figure 7. Pharmaceutical Company Picture
Figure 8. Biotechnology Company Picture
Figure 9. Generic Company Picture
Figure 10. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share in 2019
Figure 19. Global Top 10 Players Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Regions (2015-2020)
Figure 23. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Regions in 2018
Figure 24. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 25. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 27. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 29. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Figure 30. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries in 2019
Figure 31. USA Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 32. Canada Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 34. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries in 2019
Figure 36. Germany Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 37. UK Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 38. France Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 39. Russia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 40. Italy Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries in 2019
Figure 43. China Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 44. Japan Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 45. Korea Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 46. India Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 48. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Figure 49. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries in 2019
Figure 50. Brazil Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 55. UAE Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue and Growth Rate (2015-2020)
Figure 58. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Type (2015-2020)
Figure 59. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Type in 2019
Figure 60. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share Forecast by Type (2021-2025)
Figure 61. Global API Development Revenue Growth Rate (2015-2020)
Figure 62. Global Manufacturing Revenue Growth Rate (2015-2020)
Figure 63. Global Drug Delivery Revenue Growth Rate (2015-2020)
Figure 64. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Application (2015-2020)
Figure 65. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Share by Application in 2019
Figure 66. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Market Share Forecast by Application (2021-2025)
Figure 67. Global Pharmaceutical Company Revenue Growth Rate (2015-2020)
Figure 68. Global Biotechnology Company Revenue Growth Rate (2015-2020)
Figure 69. Global Generic Company Revenue Growth Rate (2015-2020)
Figure 70. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
Figure 74. Europe Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
Figure 76. South America Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Bio Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel